Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome, leaky guts, and infection: Metabolic syndrome often accompanies obesity and hyperglycemia and is associated with a breakdown in the integrity of the intestinal barrier and increased risk of systemic infection. Thaiss et al. found that mice with systemic infection of a Salmonella analog, Citrobacter rodentium , also exhibited hyperglycemia. Deletion of the glucose transporter GLUT2 altered sensitivity to chemically induced epithelial permeability and protected mice from pathogen invasion. The authors also found a correlation in humans between glycated hemoglobin (an indicator of hyperglycemia) and serum levels of pathogen recognition receptor ligands. Science , this issue p. 1376
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thaiss et al. clearly showed that hyperglycemia drives intestinal permeability by the glucose transporter GLUT2-dependent transcriptional reprogramming of intestinal epithelial cells, resulting in changes in tight and adherence junction integrity, and a systemic influx of microbial products into portal blood [274].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [274]
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types
Jaitin, D. A., Kenigsberg, E., Keren-Shaul, H., Elefant, N., Paul, F., Zaretsky, I., Mildner, A., Cohen, N., Jung, S., Tanay, A., et al. (2014) · Science · doi:10.1126/science.1247651 · Cited by 1,795
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684
Cited by
High-performance medicine: the convergence of human and artificial intelligence
Topol, E. J. (2019) · Nature Medicine · doi:10.1038/s41591-018-0300-7 · Cited by 10,450
Gut microbiota in human metabolic health and disease
Fan, Y., & Pedersen, O. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0433-9 · Cited by 4,724
The intestinal microbiota fuelling metabolic inflammation
Tilg, H., Zmora, N., Adolph, T. E., & Elinav, E. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0198-4 · Cited by 1,089
Self-citationLeaky gut: mechanisms, measurement and clinical implications in humans
Camilleri, M. (2019) · Gut · doi:10.1136/gutjnl-2019-318427 · Cited by 1,081
Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body
Cristofori, F., Dargenio, V. N., Dargenio, C., Miniello, V. L., Barone, M., & Francavilla, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.578386 · Cited by 912
“TMAO is able to activate macrophage and platelet inflammatory response causing endothelial dysfunction, vascular inflammation, and ultimately increasing the risk of cardiovascular disease (50).”
BackgroundWestern Diet and the Immune System: An Inflammatory Connection
Christ, A., Lauterbach, M., & Latz, E. (2019) · Immunity · doi:10.1016/j.immuni.2019.09.020 · Cited by 907
Gut-liver axis: Pathophysiological concepts and clinical implications
Tilg, H., Adolph, T. E., & Trauner, M. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.017 · Cited by 843
Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development
Ghosh, S. S., Wang, J., Yannie, P. J., & Ghosh, S. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz039 · Cited by 759
“Hyperglycemia increases intestinal permeability via GLUT2-dependent transcriptional reprogramming of the intestinal cells, leading to the reduced expression of tight junction proteins, and in humans the systemic influx of intestinal bacteria-derived products correlates with individualized glycemic control [102].”
BackgroundParacellular permeability and tight junction regulation in gut health and disease
Horowitz, A., Chanez-Paredes, S. D., Haest, X., & Turner, J. R. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00766-3 · Cited by 687
Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes
Scheithauer, T. P. M., Rampanelli, E., Nieuwdorp, M., Vallance, B. A., Verchere, C. B., van Raalte, D. H., & Herrema, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.571731 · Cited by 673
“Further, systemic toll like receptor (TLR) ligands were positively correlated with the long-term glucose marker HbA1c in humans (177).”
BackgroundRole of gut microbiota-generated short-chain fatty acids in metabolic and cardiovascular health
Chambers, E. S., Preston, T., Frost, G., & Morrison, D. J. (2018) · Current Nutrition Reports · doi:10.1007/s13668-018-0248-8 · Cited by 691
The gut microbiome and metabolic syndrome
Dabke, K., Hendrick, G., & Devkota, S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129194 · Cited by 654
“They carefully dissect the roles of leptin, the gut microbiome, and obesity in barrier function through systematic screening in multiple animal models and humans and ultimately determine that intracellular hyperglycemia in the intestinal epithelium, among the many factors that define dysmetabolism, is the driver (85).”
BackgroundInfluentialAdvances in oral peptide therapeutics
Drucker, D. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0053-0 · Cited by 646
The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System
Daryabor, G., Atashzar, M. R., Kabelitz, D., Meri, S., & Kalantar, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01582 · Cited by 581
“Interestingly, the reversal of hyperglycemia, conditional deletion of GLUT2 from the IECs and inhibition of glucose metabolism will fix the barrier dysfunction and prevent the spread of bacteria (76).”
BackgroundSpermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice
Ma, L., Ni, Y., Wang, Z., Tu, W., Ni, L., Zhuge, F., Zheng, A., Hu, L., Zhao, Y., Zheng, L., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1832857 · Cited by 593
“Intestinal barrier dysfunction and the subsequent translocation of bacteria and bacterial products are now considered to be important mechanisms associated with obesity.(4,5) Impaired barrier function could result in enhanced intestinal permeability and thereby facilitate the translocation of microbiota-derived endoto…”
BackgroundIntestinal Barrier in Human Health and Disease
Di Tommaso, N., Gasbarrini, A., & Ponziani, F. R. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182312836 · Cited by 533
“Indeed, chronic hyperglycemia drives intestinal barrier dysregulation by direct action on gene transcription [129].”
BackgroundGut barrier disruption and chronic disease
Martel, J., Chang, S.-H., Ko, Y.-F., Hwang, T.-L., Young, J. D., & Ojcius, D. M. (2022) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2022.01.002 · Cited by 514
“Moreover, systemic in fl ux of microbial products correlates with levels of hemoglobin A1c (HbA1c), a marker of poor glycemic control in humans [46].”
BackgroundLópez-Otín, C., & Kroemer, G. (2021) · Cell · doi:10.1016/j.cell.2020.11.034 · Cited by 499
Role of the gut microbiota in type 2 diabetes and related diseases
Yang, G., Wei, J., Liu, P., Zhang, Q., Tian, Y., Hou, G., Meng, L., Xin, Y., & Jiang, X. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154712 · Cited by 418
Beli, E., Yan, Y., Moldovan, L., Vieira, C. P., Gao, R., Duan, Y., Prasad, R., Bhatwadekar, A., White, F. A., Townsend, S. D., et al. (2018) · Diabetes · doi:10.2337/db18-0158 · Cited by 365
“Our results are in agreement with a recent study demonstrating that hyperglycemia drives the increased intestinal permeability observed in diabetes (38).”
ResultImplication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases
Stolfi, C., Maresca, C., Monteleone, G., & Laudisi, F. (2022) · Biomedicines · doi:10.3390/biomedicines10020289 · Cited by 339
“Glucose/Fructose TJ and AJ proteins dysfunction, increased susceptibility to pathogen infection, gut dysbiosis, metabolic syndrome, oxidative stress, and chronic inflammation [44,96]”
BackgroundDiabetes, infection risk and COVID-19
Erener, S. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101044 · Cited by 351
“Given the reported decrease in intestinal barrier function with hyperglycemia and concomitant increase in systemic spread of enteric pathogens [23], individuals with hyperglycemia may be more susceptibleto the entry of bacteria into their system.”
Gut Microbiota and Intestinal Trans-Epithelial Permeability
Allam-Ndoul, B., Castonguay-Paradis, S., & Veilleux, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176402 · Cited by 351
“Similarly, inadequate glycemic control in humans has been associated with increased translocation of microbial products in the circulation [35].”
BackgroundInfluentialExcessive intake of sugar: An accomplice of inflammation
Ma, X., Nan, F., Liang, H., Shu, P., Fan, X., Song, X., Hou, Y., & Zhang, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.988481 · Cited by 314
“A landmark study shows that type 2 diabetes can lead to intestinal barrier dysfunction through transcriptional reprogramming of intestinal epithelial cells and altered tight adhesion junction integrity; it can also increase disease by causing changes in gut microbial metabolism susceptibility (86).”
BackgroundChu, H., Duan, Y., Yang, L., & Schnabl, B. (2019) · Gut · doi:10.1136/gutjnl-2018-316307 · Cited by 354
Craven, L., Rahman, A., Nair Parvathy, S., Beaton, M., Silverman, J., Qumosani, K., Hramiak, I., Hegele, R., Joy, T., Meddings, J., et al. (2020) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000661 · Cited by 342
Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus
Zhou, Z., Sun, B., Yu, D., & Zhu, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.834485 · Cited by 327
Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
Stillhart, C., Vučićević, K., Augustijns, P., Basit, A. W., Batchelor, H., Flanagan, T. R., Gesquiere, I., Greupink, R., Keszthelyi, D., Koskinen, M., et al. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105280 · Cited by 320
Exploring the emerging role of the microbiome in cancer immunotherapy
Fessler, J., Matson, V., & Gajewski, T. F. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0574-4 · Cited by 319
Intestinal barriers protect against disease
Citi, S. (2018) · Science · doi:10.1126/science.aat0835 · Cited by 313
Qi, X., Zhang, Y., Zhang, Y., Luo, F., Song, K., Wang, G., & Ling, F. (2023) · Microbiome · doi:10.1186/s40168-023-01574-2 · Cited by 285
“B12 maintains normal expression of gut tight junction proteins after the pathogen infection Permeability of the gut barrier is the basis for the formation of infection outcomes in the gut by pathogens [84, 85].”
BackgroundThe metabolic nature of inflammatory bowel diseases
Adolph, T. E., Meyer, M., Schwärzler, J., Mayr, L., Grabherr, F., & Tilg, H. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00658-y · Cited by 296
Chakaroun, R., Massier, L., & Kovacs, P. (2020) · Nutrients · doi:10.3390/nu12041082 · Cited by 289
Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment
Holt, R. I. G., Cockram, C. S., Ma, R. C. W., & Luk, A. O. Y. (2024) · Diabetologia · doi:10.1007/s00125-024-06102-x · Cited by 250
“In addition to this being considered an important contributor to the metabolic dysfunction and insulin resistance [56], the microbiome contributes to the increased risk of enteric and other systemic infections in diabetes [49, 57].”
BackgroundIntestinal barrier permeability: the influence of gut microbiota, nutrition, and exercise
Dmytriv, T. R., Storey, K. B., & Lushchak, V. I. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1380713 · Cited by 246
“For example, several studies show that hyperglycemia, a key feature of diabetes, induces intestinal barrier dysfunction (Thaiss et al., 2018; Dubois et al., 2023).”
BackgroundMishra, S. P., Wang, B., Jain, S., Ding, J., Rejeski, J., Furdui, C. M., Kitzman, D. W., Taraphder, S., Brechot, C., Kumar, A., et al. (2023) · Gut · doi:10.1136/gutjnl-2022-327365 · Cited by 281
“Although hyperglycaemia induces a breakdown of tight junction barriers and elevated gut permeability, 27 suggesting that obese microbiota dysbiosis and impairment in glucose metabolism are bidirectional and the exact mechanisms of how microbiota dysbiosis or hyperglycaemia elevates gut permeability…”
Association Between Soft Drink Consumption and Mortality in 10 European Countries
Mullee, A., Romaguera, D., Pearson-Stuttard, J., Viallon, V., Stepien, M., Freisling, H., Fagherazzi, G., Mancini, F. R., Boutron-Ruault, M.-C., Kühn, T., et al. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.2478 · Cited by 269
Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders
Singh, R., Zogg, H., Wei, L., Bartlett, A., Ghoshal, U. C., Rajender, S., & Ro, S. (2021) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm20149 · Cited by 259
“However, barrier function is restored and the microbiota is contained upon treatment and management of hyperglycemia, intestinal epithelial-specific glucose transporter 2 deletion, or by inhibition of glucose metabolism.(124) Glycemic control, indicated by glycated hemoglobin levels, was shown to correlate with the sy…”
BackgroundThe Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation
Rahman, M. M., Islam, F., -Or-Rashid, M. H., Mamun, A. A., Rahaman, M. S., Islam, M. M., Meem, A. F. K., Sutradhar, P. R., Mitra, S., Mimi, A. A., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.903570 · Cited by 253
“The movement of bacteria and/or their cell wall components is linked to hyperglycemia and increased gut permeability, which triggers an inflammatory process linked to obesity and insulin resistance (Thaiss et al., 2018).”
BackgroundMannose ameliorates experimental colitis by protecting intestinal barrier integrity
Dong, L., Xie, J., Wang, Y., Jiang, H., Chen, K., Li, D., Wang, J., Liu, Y., He, J., Zhou, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32505-8 · Cited by 261
Gut microbiota and metabolic syndrome
Wang, P.-X., Deng, X.-R., Zhang, C.-H., & Yuan, H.-J. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000696 · Cited by 246
“Host blood glycemia induces barrier dysfunction through glucose transporter 2.([44]) Other intraluminal mechanisms include increased bile acid concentration and the appearance of exudative diarrhea that disrupts the gut barrier, reducing the thickness of the mucus, putting epithelial cells in direct contact with bacte…”
BackgroundType 2 diabetes influences bacterial tissue compartmentalisation in human obesity
Anhê, F. F., Jensen, B. A. H., Varin, T. V., Servant, F., Van Blerk, S., Richard, D., Marceau, S., Surette, M., Biertho, L., Lelouvier, B., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0178-9 · Cited by 227
Tryptophan Dietary Impacts Gut Barrier and Metabolic Diseases
Taleb, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02113 · Cited by 236
“We recently showed that IDO1 deletion or inhibition in the context of MetS improved insulin sensitivity, decreased endotoxemia, and chronic inflammation, and positively regulated lipid metabolism in liver, and adipose tissues.”
BackgroundInfluentialAltered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
Sircana, A., Framarin, L., Leone, N., Berrutti, M., Castellino, F., Parente, R., De Michieli, F., Paschetta, E., & Musso, G. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1057-6 · Cited by 223
Diet, inflammation and the gut microbiome: mechanisms for obesity-associated cognitive impairment
Leigh, S.-J., & Morris, M. J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165767 · Cited by 221
Intestinal Mucosal Mast Cells: Key Modulators of Barrier Function and Homeostasis
Albert-Bayo, M., Paracuellos, I., González-Castro, A. M., Rodríguez-Urrutia, A., Rodríguez-Lagunas, M. J., Alonso-Cotoner, C., Santos, J., & Vicario, M. (2019) · Cells · doi:10.3390/cells8020135 · Cited by 216
“An abnormal intestinal barrier has major implications for human health, being involved in the origin and development of many digestive (coeliac disease, IBD, IBS, food allergy) and extra-digestive diseases (schizophrenia, diabetes and sepsis, among others) [29,30].”
BackgroundGut microbiota in overweight and obesity: crosstalk with adipose tissue
Cani, P. D., & Van Hul, M. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00867-z · Cited by 194
“These factors include a high-fat diet 78 , excessive alcohol consumption 130 , obesity 131–133 , hyperglycaemia 134 and lack of dietary fibres 135 , all contributing to distinct modifications in the integrity of the gut barrier.”
Xu, J., Liang, R., Zhang, W., Tian, K., Li, J., Chen, X., Yu, T., & Chen, Q. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.12986 · Cited by 209
“Malfunction of the intestinal barrier promotes the absorption of pathogens and toxins from the lumen, which induces intestinal inflammation and hyperglycemia deterioration.(3,4) These pathological alterations worsen DM prognosis.”
BackgroundEffects of dietary components on intestinal permeability in health and disease
Khoshbin, K., & Camilleri, M. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00245.2020 · Cited by 195
Genser, L., Aguanno, D., Soula, H. A., Dong, L., Trystram, L., Assmann, K., Salem, J., Vaillant, J., Oppert, J., Laugerette, F., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5134 · Cited by 187
“Recently, Thaiss et al demonstrated a hyperglycemia-mediated barrier disruption through a mechanism initiated at the basal membrane [47].”
BackgroundHigh-Throughput Screen Identifies Host and Microbiota Regulators of Intestinal Barrier Function
Grosheva, I., Zheng, D., Levy, M., Polansky, O., Lichtenstein, A., Golani, O., Dori-Bachash, M., Moresi, C., Shapiro, H., Del Mare-Roumani, S., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.07.003 · Cited by 198
Self-citationDiet Diurnally Regulates Small Intestinal Microbiome-Epithelial-Immune Homeostasis and Enteritis
Tuganbaev, T., Mor, U., Bashiardes, S., Liwinski, T., Nobs, S. P., Leshem, A., Dori-Bachash, M., Thaiss, C. A., Pinker, E. Y., Ratiner, K., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.027 · Cited by 190
“Similarly, quantification of pattern recognition receptors (PRRs) ligand concentrations (Thaiss et al., 2018) in the portal vein (Figure 6C), peripheral blood (Figure S6L), and the liver (Figure S6M) demonstrated a diurnal fluctuation of barrier function.”
BackgroundSelf-citationAdipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes
Massier, L., Chakaroun, R., Tabei, S., Crane, A., Didt, K. D., Fallmann, J., von Bergen, M., Haange, S.-B., Heyne, H., Stumvoll, M., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-320118 · Cited by 194
Autophagy controls mucus secretion from intestinal goblet cells by alleviating ER stress
Naama, M., Telpaz, S., Awad, A., Ben-Simon, S., Harshuk-Shabso, S., Modilevsky, S., Rubin, E., Sawaed, J., Zelik, L., Zigdon, M., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.01.006 · Cited by 177
Intestinal Stem Cell Aging: Origins and Interventions
Jasper, H. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034359 · Cited by 175
“The study further showed that systemic influx of intestinal microbiome products correlates with individualized glycemic control in humans (171).”
BackgroundMicrobial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target
Wang, K., Zhang, Z., Hang, J., Liu, J., Guo, F., Ding, Y., Li, M., Nie, Q., Lin, J., Zhuo, Y., et al. (2023) · Science · doi:10.1126/science.add5787 · Cited by 173
“(E) Activity of hDPP4 and nine active microbial DPP4 homologs against GLP-1(7-37), n = 3 biological replicates per group.”
BackgroundInfluentialDysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy
Huang, Y., Wang, Z., Ma, H., Ji, S., Chen, Z., Cui, Z., Chen, J., & Tang, S. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.646348 · Cited by 180
Carbajo-Pescador, S., Porras, D., García-Mediavilla, M. V., Martínez-Flórez, S., Juarez-Fernández, M., Cuevas, M. J., Mauriz, J. L., González-Gallego, J., Nistal, E., & Sánchez-Campos, S. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039206 · Cited by 178
“…in tight junctions and epithelial adhesion molecules can increase the intestinal barrier permeability, allowing the influx of immune-stimulatory microbial metabolites across the epithelial layer, leading to mucosal infections commonly observed in obese/NAFLD patients (Thaiss et al., 2018).”
New Insights and Potential Therapeutic Interventions in Metabolic Diseases
Clemente‐Suárez, V. J., Martín-Rodríguez, A., Redondo-Flórez, L., López-Mora, C., Sepulveda, R. A. Y., & Tornero-Aguilera, J. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310672 · Cited by 197
Sanchez, K. K., Chen, G. Y., Schieber, A. M. P., Redford, S. E., Shokhirev, M. N., Leblanc, M., Lee, Y. M., & Ayres, J. S. (2018) · Cell · doi:10.1016/j.cell.2018.07.016 · Cited by 175
“HFD has been previously suggested to cause leaky gut in C57BL/6 mice and render mice more susceptible to CR extraintestinal dissemination (Thaiss et al., 2018) but does not in DBA/2J mice (Figures S6A–S6D).”
Ageing, metabolism and the intestine
Funk, M. C., Zhou, J., & Boutros, M. (2020) · EMBO reports · doi:10.15252/embr.202050047 · Cited by 164
“Dysfunction of the intestinal barrier is associated with local and systemic disorders, including inflammatory bowel disease, obesity, metabolic diseases, liver disease, and lung and brain dysfunctions (Nicoletti, 2015; Chelakkot et al, 2018; Thaiss et al, 2018).”
Cremonini, E., Daveri, E., Mastaloudis, A., Adamo, A. M., Mills, D., Kalanetra, K., Hester, S. N., Wood, S. M., Fraga, C. G., & Oteiza, P. I. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101269 · Cited by 163
Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome
Lee, Y., Kamada, N., & Moon, J. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114021 · Cited by 165
“logical states, IBD [7,97–99], autoimmune diseases [100], and systemic infection [101] (Fig.”
BackgroundXiao, S., Liu, C., Chen, M., Zou, J., Zhang, Z., Cui, X., Jiang, S., Shang, E., Qian, D., & Duan, J. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10174-w · Cited by 169
Zhang, H.-Y., Tian, J.-X., Lian, F.-M., Li, M., Liu, W.-K., Zhen, Z., Liao, J.-Q., & Tong, X.-L. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110857 · Cited by 161
Mitochondrial metabolic reprogramming in diabetic kidney disease
Fan, X., Yang, M., Lang, Y., Lu, S., Kong, Z., Gao, Y., Shen, N., Zhang, D., & Lv, Z. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06833-0 · Cited by 182
“Hyperglycemia causes Imbalance of gut micro-organisms, intestinal barrier dysfunction and increased permeability of the intestinal mucosa, resulting in leaky gut [27].”
BackgroundChristensen, L., Vuholm, S., Roager, H. M., Nielsen, D. S., Krych, L., Kristensen, M., Astrup, A., & Hjorth, M. F. (2019) · The Journal of Nutrition · doi:10.1093/jn/nxz198 · Cited by 162
Processed foods drive intestinal barrier permeability and microvascular diseases
Snelson, M., Tan, S. M., Clarke, R., de Pasquale, C., Thallas‐Bonke, V., Nguyen, T.-V., Penfold, S. A., Harcourt, B. E., Sourris, K. C., Lindblom, R. S. J., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe4841 · Cited by 167
Possible Benefits of Faecalibacterium prausnitzii for Obesity-Associated Gut Disorders
Maioli, T. U., Nogués, E. B., Torres, L., Barbosa, S. C., Martins, V. D., Langella, P., Azevedo, V., & Chatel, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.740636 · Cited by 174
“For example, in db/dbmice with controlled food intake or in mice treated with streptozotocin, high levels of blood glucose were associated with high intestinal permeability and increased expression of PRP (pathogen recognition patterns) in lymphoid organs (Thaiss et al., 2018).”
BackgroundEmerging concepts in intestinal immune control of obesity-related metabolic disease
Khan, S. M., Luck, H., Winer, S., & Winer, D. A. (2021) · Nature Communications · doi:10.1038/s41467-021-22727-7 · Cited by 169
Potential Benefits of Probiotics and Prebiotics for Coronary Heart Disease and Stroke
Wu, H., & Chiou, J. A. (2021) · Nutrients · doi:10.3390/nu13082878 · Cited by 169
Zhou, W., Yang, T., Xu, W., Huang, Y., Ran, L., Yan, Y., Mi, J., Lu, L., Sun, Y., Zeng, X., et al. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119626 · Cited by 149
Wen, L., Sheng, Z., Wang, J., Jiang, Y., & Yang, B. J. (2021) · Food Chemistry · doi:10.1016/j.foodchem.2021.131374 · Cited by 156
Arab, H. H., Al‐Shorbagy, M. Y., & Saad, M. A. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109368 · Cited by 152
Vallianou, N. G., Kounatidis, D. C., Tsilingiris, D., Panagopoulos, F., Christodoulatos, G. S., Evangelopoulos, A. A., Karampela, Ι., & Dalamaga, Μ. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076755 · Cited by 161
Harbison, J. E., Roth‐Schulze, A. J., Giles, L. C., Tran, C. D., Ngui, K., Penno, M. A. S., Thomson, R. L., Wentworth, J. M., Colman, P. G., Craig, M. E., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12865 · Cited by 162
Gut microbiome, prebiotics, intestinal permeability and diabetes complications
Snelson, M., de Pasquale, C., Ekinci, E. I., & Coughlan, M. T. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101507 · Cited by 153
Adaptation of the Gut Microbiota to Modern Dietary Sugars and Sweeteners
Rienzi, S. C. D., & Britton, R. A. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz118 · Cited by 144
“These changes are hypothesized to cause the reduced mucus thickness and impaired barrier integrity observed under hyperglycemia, which in turn leads to endotoxin translocation, an immune response, and alterations in the gut microbiome (68, 90).”
BackgroundMethodCan’t or Won’t? Immunometabolic Constraints on Dopaminergic Drive
Treadway, M. T., Cooper, J. A., & Miller, A. H. (2019) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2019.03.003 · Cited by 153
“Indeed, circulating MAMPS secondary to dysregulation of the gut microbiome and a leaky gut (dysbiosis) signal the consequences of poor dietary habits, hyperglycemia, psychological or physical stressors, and gastrointestinal disease by activating PRRs and the inflammatory response [63, 64].”
BackgroundThe immuno-oncological challenge of COVID-19
Derosa, L., Melenotte, C., Griscelli, F., Gachot, B., Marabelle, A., Kroemer, G., & Zitvogel, L. (2020) · Nature Cancer · doi:10.1038/s43018-020-00122-3 · Cited by 149
Periportal macrophages protect against commensal-driven liver inflammation
Miyamoto, Y., Kikuta, J., Matsui, T., Hasegawa, T., Fujii, K., Okuzaki, D., Liu, Y.-C., Yoshioka, T., Seno, S., Motooka, D., et al. (2024) · Nature · doi:10.1038/s41586-024-07372-6 · Cited by 135
“…would become crucial when the intestinal barrier is impaired, which would cause an increased number of pathogens to be translocated into the liver, as observed in conditions such as colitis 28 , non-alcoholic fatty liver disease 29,30 , autoimmune hepatitis 31,32 , obesity 33 and diabetes 33 .”
The Gut Microbiome Regulates Psychological-Stress-Induced Inflammation
Xu, C., Lee, S. K., Zhang, D., & Frenette, P. S. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.025 · Cited by 146
“The regulation of gut permeability to maintain health is consistent with other studies showing that its disruption may lead to diseases, including obesity, diabetes, and colitis (Mohanan et al., 2018; Thaiss et al., 2018).”
ResultThe role of GLUT2 in glucose metabolism in multiple organs and tissues
Sun, B., Chen, H., Xue, J., Li, P., & Fu, X. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08535-w · Cited by 148
“Mice models of obesity and diabetes showed that hyperglycemia could alter the GLUT2-dependent transcription in enterocytes, influence the adhesion and integrity of tight junction between enterocytes, consequently changing the permeability of the intestinal barrier [36].”
BackgroundE-cadherin Beyond Structure: A Signaling Hub in Colon Homeostasis and Disease
Daulagala, A. C., Bridges, C., & Kourtidis, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112756 · Cited by 139
“In a recent work, it was demonstrated that obesity and ensuing diabetes and hyperglycemia negatively impact intestinal barrier function, which, in turn, results in microbial infection and inflammation, a common precursor to CRC [36].”
BackgroundImpaired Intestinal Barrier and Tissue Bacteria: Pathomechanisms for Metabolic Diseases
Massier, L., Blüher, M., Kovacs, P. L., & Chakaroun, R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.616506 · Cited by 134
“While the influx of microbial products has been suggested to underlie chronic inflammation observed in metabolic disease and more specifically T2D (9), clinical features of metabolic diseases such as hyperglycemia in T2D have been associated with increased influx of microbial products in humans reflective of glucotoxi…”
BackgroundAbraham, C., Abreu, M. T., & Turner, J. R. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.12.288 · Cited by 141
Mechanisms and consequences of gut commensal translocation in chronic diseases
Fine, R. L., Vieira, S. M., Gilmore, M. S., & Kriegel, M. A. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1629236 · Cited by 136
Luo, Z., Ji, Y., Gao, H., Reis, F. C. G., Bandyopadhyay, G. K., Jin, Z., Ly, C., Chang, Y., Zhang, D., Kumar, D., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.10.042 · Cited by 133
Liu, H., Zhang, M., Ma, Q., Tian, B., Nie, C., Chen, Z., & Li, J. (2020) · Food & Function · doi:10.1039/d0fo00855a · Cited by 133
Niche-specific functional heterogeneity of intestinal resident macrophages
Viola, M. F., & Boeckxstaens, G. E. (2020) · Gut · doi:10.1136/gutjnl-2020-323121 · Cited by 129
“122 133 Whether HFD drives dysfunction of blood vessel-associated macrophages is as yet unknown, however, it has been shown to promote an accumulation of pro-inflammatory macrophages in the colon, suggesting that local inflammation may affect local macrophage phenotype imprinting.”
BackgroundXing, C., Zhu, H., Dou, X., Gao, L., Baddi, S., Zou, Y., Zhao, C., Peng, Y., Fang, Y., & Feng, C. (2023) · ACS Nano · doi:10.1021/acsnano.2c10039 · Cited by 123
Microbial regulation of hexokinase 2 links mitochondrial metabolism and cell death in colitis
Hinrichsen, F., Hamm, J., Westermann, M., Schröder, L. C., Shima, K., Mishra, N., Walker, A., Sommer, N., Klischies, K., Prasse, D., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.11.004 · Cited by 125
Unraveling the Role of Leptin in Liver Function and Its Relationship with Liver Diseases
Martinez‐Uña, M., López‐Mancheño, Y., Diéguez, C., Fernandez-Rojo, M. A., & Novelle, M. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249368 · Cited by 127
Sodium Butyrate Improves Liver Glycogen Metabolism in Type 2 Diabetes Mellitus
Zhang, W., Zhao, T., Gui, D., Gao, C., Gu, J., Gan, W.-J., Huang, W. G., Xu, Y., Zhou, H., Chen, W.-N., et al. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b02083 · Cited by 120
Immune-Microbiota Interplay and Colonization Resistance in Infection
Leshem, A., Liwinski, T., & Elinav, E. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.03.001 · Cited by 126
“If these barrier functions are compromised, the risk of infection significantly increases (Desai et al., 2016b; Thaiss et al., 2018).”
BackgroundSelf-citationCamilleri, M., Lyle, B. J., Madsen, K. L., Sonnenburg, J. L., Verbeke, K., & Wu, G. D. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00063.2019 · Cited by 125
“recently demonstrated in an elegant set of in vitro and mouse experiments that hyperglycemia, even in the absence of obesity, could increase gut permeability via alterations in tight junction and adherens junction integrity (203).”
BackgroundImmunity, microbiota and kidney disease
Knauf, F., Brewer, J. R., & Flavell, R. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0118-7 · Cited by 123
Palmitic acid damages gut epithelium integrity and initiates inflammatory cytokine production
Ghezzal, S., Postal, B. G., Quévrain, E., Brot, L., Seksik, P., Leturque, A., Thenet, S., & Carrière, V. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.158530 · Cited by 117
Guo, Y., Zhu, X., Zeng, M., Qi, L., Tang, X., Wang, D., Zhang, M., Xie, Y., Li, H., Yang, X., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01443-2 · Cited by 115
Fu, Y., Zhao, X., Wang, L., Li, K., Jiang, N., Zhang, S., Wang, R., Zhao, Y., & Yang, W. M. (2024) · Advanced Materials · doi:10.1002/adma.202309972 · Cited by 110
Metadata
- Authors
- Thaiss, C. A., Levy, M., Grosheva, I., Zheng, D., Soffer, E., Blacher, E., Braverman, S., Tengeler, A. C., Barak, O., Elazar, M., Ben-Zeev, R., Lehavi-Regev, D., Katz, M. N., Pevsner-Fischer, M., Gertler, A., Halpern, Z., Harmelin, A., Aamar, S., Serradas, P., Grosfeld, A., Shapiro, H., Geiger, B., & Elinav, E.
- Affiliations
- Weizmann Institute of Science (IL)
- Hebrew University of Jerusalem (IL)
- Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
- Tel Aviv Sourasky Medical Center (IL)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Elinav, Eran
- ORCID
- Venue
- Science
- Published
- 2018-03-23
- Volume
- 359
- Issue
- 6382
- Pages
- 1376-1383
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2794419196
- Cited by
- 942
- References
- 56
- Citations by year
- 2026: 91 · 2025: 134 · 2024: 129 · 2023: 102 · 2022: 142 · 2021: 126 · 2020: 102 · 2019: 74 · 2018: 38
- FWCI
- 30.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Science (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Bill & Melinda Gates Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- hyperglycemia, intestinal barrier dysfunction, gastrointestinal infections, obesity, diabetes mellitus, GLUT2, intestinal epithelial cells, tight junctions, adherens junctions, intestinal permeability, microbial translocation, HbA1c, glycemic control, gut microbiota, systemic inflammation
- MeSH terms
- Gastrointestinal Microbiome, Animals, Blood Glucose, Diabetes Mellitus, Experimental, Escherichia coli Infections, Glucose, Humans, Hyperglycemia, Intestinal Diseases, Intestinal Mucosa, Mice, Inbred Strains, Obesity, Permeability, Streptozocin, Gene Deletion, Caco-2 Cells, Citrobacter rodentium, Glucose Transporter Type 2, Mice, Enteropathogenic Escherichia coli, Receptors, Leptin, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.